Skip to main content
. 2022 May 26;80:104077. doi: 10.1016/j.ebiom.2022.104077

Figure 3.

Figure 3

Prognostic impact of baseline calprotectin level for each cohort adjusted for age, sex, body mass index and comorbidities, including cancer, diabetes, cardio-vascular and lung diseases.